Corvus Pharmaceuticals (CRVS) Cash & Equivalents (2015 - 2026)
Corvus Pharmaceuticals' Cash & Equivalents was $18.91 million in Q2 2026, up 28.7% from $14.69 million a year earlier but down 52.9% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Cash & Equivalents (2015 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Corvus Pharmaceuticals came in at $4.58 million, down 47.6% from FY2024.
- Cash & Equivalents has now declined for four consecutive years, with a five-year compound annual growth rate of -22.6% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $8.74 million in FY2024 (-30.7%), $12.62 million in FY2023 (-4.1%), $13.16 million in FY2022 (-79.3%) and $63.46 million in FY2021 (+285.6%).
- Quarterly Cash & Equivalents has moved between $2.87 million (Q3 2025) and $72.3 million (Q3 2021) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in two of the last eight quarters, with growth averaging 62.9%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2026 (growth of 702.2%); the worst was Q4 2022 (a decline of 79.3%).
- Per Business Quant data, CRVS's Cash & Equivalents in the three quarters before Q2 2026 was $40.1 million (Q1 2026), $4.58 million (Q4 2025) and $2.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Corvus Pharmaceuticals | 919.44 Mn | 407.88 Mn | - | 18.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.91 Mn |
| Mar 31, 2026 | 40.10 Mn |
| Dec 31, 2025 | 4.58 Mn |
| Sep 30, 2025 | 2.87 Mn |
| Jun 30, 2025 | 14.69 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 14.84 Mn |
| Mar 31, 2024 | 7.46 Mn |
| Dec 31, 2023 | 12.62 Mn |
| Sep 30, 2023 | 20.11 Mn |
| Jun 30, 2023 | 7.66 Mn |
| Mar 31, 2023 | 9.65 Mn |
| Dec 31, 2022 | 13.16 Mn |
| Sep 30, 2022 | 24.59 Mn |
| Jun 30, 2022 | 28.48 Mn |
| Mar 31, 2022 | 31.46 Mn |
| Dec 31, 2021 | 63.46 Mn |
| Sep 30, 2021 | 72.30 Mn |
API Access
Corvus Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();